Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2258611rdf:typepubmed:Citationlld:pubmed
pubmed-article:2258611lifeskim:mentionsumls-concept:C0007600lld:lifeskim
pubmed-article:2258611lifeskim:mentionsumls-concept:C0086418lld:lifeskim
pubmed-article:2258611lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:2258611lifeskim:mentionsumls-concept:C0020792lld:lifeskim
pubmed-article:2258611lifeskim:mentionsumls-concept:C0086574lld:lifeskim
pubmed-article:2258611lifeskim:mentionsumls-concept:C0034819lld:lifeskim
pubmed-article:2258611lifeskim:mentionsumls-concept:C1749467lld:lifeskim
pubmed-article:2258611pubmed:issue12lld:pubmed
pubmed-article:2258611pubmed:dateCreated1991-1-28lld:pubmed
pubmed-article:2258611pubmed:abstractTextA clone was isolated from the human lymphoid cell line YT that displayed IL-2R beta, and was found to express much higher levels of IL-2R beta than the original cells. Combining cell surface iodination, affinity labeling of the released soluble protein, and fluorescence sandwich-ELISA for both IL-2 and IL-2.(soluble)(s)IL-2R beta reactants revealed the presence of IL-2-binding protein in the culture supernatant as soluble forms of IL-2R beta. By using the fluorescence sandwich-ELISA elevated levels of sIL-2R beta were measured in culture supernatants of human T cell leukemia virus I positive T cell lines. In addition to this constitutive production of sIL-2R beta, normal PBMC could release low levels of IL-2R beta by stimulation with PHA. In contrast, this was not found in certain human T cell leukemia virus I negative T cell, B cell and macrophage lines. Immunoprecipitation of the soluble protein with IL-2R beta-specific mAb characterized it as an apparent 50- to 55-kDa molecule that is distinct from the 45-kDa soluble IL-2R alpha. Moreover, 10 to 15% of the total cell surface molecules were released into culture supernatants. These results suggest that the released IL-2R beta might serve as an immunoregulatory function in IL-2 dependent both normal and abnormal immune responses.lld:pubmed
pubmed-article:2258611pubmed:languageenglld:pubmed
pubmed-article:2258611pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2258611pubmed:citationSubsetAIMlld:pubmed
pubmed-article:2258611pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2258611pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2258611pubmed:statusMEDLINElld:pubmed
pubmed-article:2258611pubmed:monthDeclld:pubmed
pubmed-article:2258611pubmed:issn0022-1767lld:pubmed
pubmed-article:2258611pubmed:authorpubmed-author:HondaMMlld:pubmed
pubmed-article:2258611pubmed:authorpubmed-author:KitamuraKKlld:pubmed
pubmed-article:2258611pubmed:authorpubmed-author:SugamuraKKlld:pubmed
pubmed-article:2258611pubmed:authorpubmed-author:TokunagaTTlld:pubmed
pubmed-article:2258611pubmed:authorpubmed-author:TakeshitaTTlld:pubmed
pubmed-article:2258611pubmed:issnTypePrintlld:pubmed
pubmed-article:2258611pubmed:day15lld:pubmed
pubmed-article:2258611pubmed:volume145lld:pubmed
pubmed-article:2258611pubmed:ownerNLMlld:pubmed
pubmed-article:2258611pubmed:authorsCompleteYlld:pubmed
pubmed-article:2258611pubmed:pagination4131-5lld:pubmed
pubmed-article:2258611pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2258611pubmed:meshHeadingpubmed-meshheading:2258611-...lld:pubmed
pubmed-article:2258611pubmed:meshHeadingpubmed-meshheading:2258611-...lld:pubmed
pubmed-article:2258611pubmed:meshHeadingpubmed-meshheading:2258611-...lld:pubmed
pubmed-article:2258611pubmed:meshHeadingpubmed-meshheading:2258611-...lld:pubmed
pubmed-article:2258611pubmed:meshHeadingpubmed-meshheading:2258611-...lld:pubmed
pubmed-article:2258611pubmed:meshHeadingpubmed-meshheading:2258611-...lld:pubmed
pubmed-article:2258611pubmed:meshHeadingpubmed-meshheading:2258611-...lld:pubmed
pubmed-article:2258611pubmed:meshHeadingpubmed-meshheading:2258611-...lld:pubmed
pubmed-article:2258611pubmed:year1990lld:pubmed
pubmed-article:2258611pubmed:articleTitleIdentification of a soluble IL-2 receptor beta-chain from human lymphoid cell line cells.lld:pubmed
pubmed-article:2258611pubmed:affiliationAIDS Research Center, National Institute of Health, Tokyo, Japan.lld:pubmed
pubmed-article:2258611pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2258611pubmed:publicationTypeIn Vitrolld:pubmed
pubmed-article:2258611pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2258611lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2258611lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2258611lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2258611lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2258611lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2258611lld:pubmed